0001104659-21-083610.txt : 20210621 0001104659-21-083610.hdr.sgml : 20210621 20210621172713 ACCESSION NUMBER: 0001104659-21-083610 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210617 FILED AS OF DATE: 20210621 DATE AS OF CHANGE: 20210621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bonello Michael J. CENTRAL INDEX KEY: 0001738327 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36732 FILM NUMBER: 211032053 MAIL ADDRESS: STREET 1: 4130 PARKLAKE AVENUE STREET 2: SUITE 400 CITY: RALEIGH STATE: NY ZIP: 27612 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PRA Health Sciences, Inc. CENTRAL INDEX KEY: 0001613859 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 463640387 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4130 PARKLAKE AVENUE STREET 2: SUITE 400 CITY: RALEIGH STATE: NC ZIP: 27612 BUSINESS PHONE: 9197868200 MAIL ADDRESS: STREET 1: 4130 PARKLAKE AVENUE STREET 2: SUITE 400 CITY: RALEIGH STATE: NC ZIP: 27612 4 1 tm2120078-5_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-06-17 0 0001613859 PRA Health Sciences, Inc. PRAH 0001738327 Bonello Michael J. C/O PRA HEALTH SCIENCES, INC. 4130 PARKLAKE AVENUE, SUITE 400 RALEIGH NC 27612 0 1 0 0 EVP & CFO Common Stock 2021-06-17 4 M 0 35661 81.61 A 47525 D Common Stock 2021-06-17 4 M 0 8334 95.94 A 55859 D Common Stock 2021-06-17 4 M 0 8556 103.30 A 64415 D Common Stock 2021-06-17 4 S 0 200 166.70 D 64215 D Common Stock 2021-06-17 4 S 0 24389 168.17 D 39826 D Common Stock 2021-06-17 4 S 0 22587 169.05 D 17239 D Common Stock 2021-06-17 4 S 0 5375 169.67 D 11864 D Stock Options (Right to Buy) 81.61 2021-06-17 4 M 0 35661 0 D 2028-04-26 Common Stock 35661 20000 D Stock Options (Right to Buy) 95.94 2021-06-17 4 M 0 8334 0 D 2029-08-13 Common Stock 8334 16666 D Stock Options (Right to Buy) 103.30 2021-06-17 4 M 0 8556 0 D 2030-06-01 Common Stock 8556 17114 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $166.55 to $166.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2), (3), (4) and (5) of this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $167.57 to $168.56, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $168.57 to $169.55, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $169.57 to $169.83, inclusive. 12,877 options vested on April 26, 2019 and 4,339 options vested on April 26, 2020 upon satisfaction of certain performance criteria. The option vests in three equal annual installments of 8,334 beginning on August 13, 2020. The option vests in three equal annual installments of 8,556 beginning on June 1, 2021. By: /s/ Christopher L. Gaenzle, by power of attorney 2021-06-21